Literature DB >> 9868893

Antibody reaction of human anti-Toxoplasma gondii positive and negative sera with Neospora caninum antigens.

H W Nam1, S W Kang, W Y Choi.   

Abstract

Anti-Neospora caninum antibody was detected in anti-Toxoplasma gondii positive and negative human sera by ELISA, western blot and immunofluorescence assay (IFA). Twelve cases out of 172 (6.7%) Toxoplasma-positive sera cross-reacted with both T. gondii and N. caninum antigens, and one out of 110 Toxoplasma-negative sera reacted with N. caninum antigen by ELISA. By western blot, all 12 sera reacted with T. gondii antigens with various banding patterns but specifically at 30 kDa (SAG1) and 22 kDa (SAG2) bands. With N. caninum antigen, the number of reactive bands was reduced, however a 43 kDa band reacted in three cases in Toxoplasma-positive sera in addition to one in Toxoplasma-negative control sera. All sera of the Toxoplasma-positive group labeled surface membrane of T. gondii, but reacted differently with N. caninum. Fluorescence was detected in surface membrane, subcellular organelles, or both in N. caninum. And one case in the Toxoplasma-negative group also reacted with N. caninum strongly in subcellular organelles. This suggested that the antibody against N. caninum may be present in human sera although the positive rate was very low in this study. The possibility of human infection with N. caninum remains to be evaluated further.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9868893      PMCID: PMC2732967          DOI: 10.3347/kjp.1998.36.4.269

Source DB:  PubMed          Journal:  Korean J Parasitol        ISSN: 0023-4001            Impact factor:   1.341


  19 in total

1.  Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein.

Authors:  A Hemphill
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

2.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

3.  Characterization of a murine monoclonal antibody generated against Neospora caninum tachyzoites by use of western blot analysis and immunoelectron microscopy.

Authors:  R A Cole; D S Lindsay; J P Dubey; M A Toivio-Kinnucan; B L Blagburn
Journal:  Am J Vet Res       Date:  1994-12       Impact factor: 1.156

4.  Detection of antibodies in serum and cerebrospinal fluid to Toxoplasma gondii by indirect latex agglutination test and enzyme-linked immunosorbent assay.

Authors:  W Y Choi; H W Nam; J H Youn; D J Kim; Y Kong; S Y Kang; S Y Cho
Journal:  Kisaengchunghak Chapchi       Date:  1992-06

5.  Neospora caninum in dogs: detection of antibodies by ELISA using an iscom antigen.

Authors:  C Björkman; A Lundén; J Holmdahl; J Barber; A J Trees; A Uggla
Journal:  Parasite Immunol       Date:  1994-12       Impact factor: 2.280

6.  Identification of a major surface protein on Neospora caninum tachyzoites.

Authors:  A Hemphill; B Gottstein
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

7.  Genetic comparison of Neospora caninum with Toxoplasma and Sarcocystis by random amplified polymorphic DNA-polymerase chain reaction.

Authors:  Z G Guo; A M Johnson
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

8.  Differentiation of Toxoplasma gondii from closely related coccidia by riboprint analysis and a surface antigen gene polymerase chain reaction.

Authors:  P J Brindley; R T Gazzinelli; E Y Denkers; S W Davis; J P Dubey; R Belfort; M C Martins; C Silveira; L Jamra; A P Waters
Journal:  Am J Trop Med Hyg       Date:  1993-03       Impact factor: 2.345

9.  Newly recognized fatal protozoan disease of dogs.

Authors:  J P Dubey; J L Carpenter; C A Speer; M J Topper; A Uggla
Journal:  J Am Vet Med Assoc       Date:  1988-05-01       Impact factor: 1.936

10.  Toxoplasma antibody titers by indirect latex agglutination test in patients of Kangnam St. Mary's Hospital and Cheju Medical Center.

Authors:  W Y Choi; H W Nam; J H Youn; W S Kim; W K Kim
Journal:  Kisaengchunghak Chapchi       Date:  1989-09
View more
  7 in total

1.  Detection of IgG antibody against Neospora caninum in cattle in Korea.

Authors:  J S Bae; D Y Kim; W S Hwang; J H Kim; N S Lee; H W Nam
Journal:  Korean J Parasitol       Date:  2000-12       Impact factor: 1.341

2.  Detection of immunoglobulin G antibodies to Neospora caninum in humans: high seropositivity rates in patients who are infected by human immunodeficiency virus or have neurological disorders.

Authors:  Janaína Lobato; Deise A O Silva; Tiago W P Mineo; Jodi D H F Amaral; Gesmar R Silva Segundo; Julia M Costa-Cruz; Marcelo S Ferreira; Aércio S Borges; José R Mineo
Journal:  Clin Vaccine Immunol       Date:  2006-01

Review 3.  Review of Neospora caninum and neosporosis in animals.

Authors:  J P Dubey; John Dubey
Journal:  Korean J Parasitol       Date:  2003-03       Impact factor: 1.341

Review 4.  Epidemiology and control of neosporosis and Neospora caninum.

Authors:  J P Dubey; G Schares; L M Ortega-Mora
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

5.  Neospora caninum: a new class of biopharmaceuticals in the therapeutic arsenal against cancer.

Authors:  Louis Lantier; Agathe Poupée-Beaugé; Anne di Tommaso; Céline Ducournau; Mathieu Epardaud; Zineb Lakhrif; Stéphanie Germon; Françoise Debierre-Grockiego; Marie-Noëlle Mévélec; Arthur Battistoni; Loïs Coënon; Nora Deluce-Kakwata-Nkor; Florence Velge-Roussel; Céline Beauvillain; Thomas Baranek; Gordon Scott Lee; Thibault Kervarrec; Antoine Touzé; Nathalie Moiré; Isabelle Dimier-Poisson
Journal:  J Immunother Cancer       Date:  2020-11       Impact factor: 13.751

6.  Lack of serologic evidence of Neospora caninum in humans, England.

Authors:  Catherine M McCann; Andrew J Vyse; Roland L Salmon; Daniel Thomas; Diana J L Williams; John W McGarry; Richard Pebody; Alexander J Trees
Journal:  Emerg Infect Dis       Date:  2008-06       Impact factor: 6.883

7.  Myeloid differentiation factor 88 is required for resistance to Neospora caninum infection.

Authors:  Tiago W P Mineo; Luciana Benevides; Neide M Silva; João S Silva
Journal:  Vet Res       Date:  2009-04-03       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.